Prostaglandin analogs and blood-aqueous barrier integrity: A flare cell meter study

Ophthalmologica

Volumn 218, Issue 5, 2004, Pages 312-317

  Cellini, M ^a,b   Caramazza, R ^a   Bonsanto, D ^a   Bernabini, B ^a   Campos, E C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bimatoprost; Chronic open angle glaucoma; Flare cell meter; Latanoprost; Travoprost

Indexed keywords

ANTIGLAUCOMA AGENT; ANTIINFECTIVE AGENT; BIMATOPROST; LATANOPROST; NEON; PROSTAGLANDIN DERIVATIVE; TRAVOPROST;

ADULT; AGE DISTRIBUTION; AGED; ANTERIOR EYE CHAMBER ANGLE; AQUEOUS HUMOR FLOW; ARTICLE; BLOOD EYE BARRIER; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMETRY; DEVICE; EYE INFLAMMATION; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LASER; MAJOR CLINICAL STUDY; MALE; MICROSCOPE; OPEN ANGLE GLAUCOMA; PHOTON; PRESSURE MEASUREMENT; RANDOMIZATION; SLIT LAMP;

ADULT; AGED; AMIDES; ANTERIOR CHAMBER; ANTIHYPERTENSIVE AGENTS; AQUEOUS HUMOR; BLOOD-AQUEOUS BARRIER; CHRONIC DISEASE; CLOPROSTENOL; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; LIPIDS; MALE; MIDDLE AGED; PROSTAGLANDINS F, SYNTHETIC; UVEITIS, ANTERIOR;

EID: 4444292559     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079472     Document Type: Article

References (30)

1. Camras CB, Alm A, Watson P, Stjernschantz J: Latanoprost, a prostaglandin analog for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. Ophthalmology 1996;103:1916-1924.
2. Netland PA, Landry T, Sullivan EK: Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132:472-484.
3. Eisenberg DL, Toris C, Camras CB: Bimatoprost and travoprost: A review of recent studies of two new glaucoma drugs. Surv Ophthalmol 2002;47(suppl 1):S105-S115.
4. Brubaker RF, Schoeff EO, Nau CB: Effects of bimatoprost, a new ocular hypotensive agent, on aqueous humor dynamics. Am J Ophthalmol 2001;131:19-24.
5. Stewart W, Kolker AE, Stewart JA: Conjunctival hyperemia in healthy subjects after shortterm dosing with latanoprost, bimatoprost, and travoprost. Am J Ophthalmol 2003;135:314-320.
6. Costagliola C, Prete AD, Incorvaia C, et al: Ocular surface changes induced by topical application of latanoprost and timolol: A shortterm study in glaucomatous patients with and without allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 2001;239:809-814.
7. Noecker RS, Dirks MS: A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 2003;135:55-63.
8. Rowe JA, Hattenhauer MG, Herman DC: Adverse side effects associated with latanoprost. Am J Ophthalmol 1997;124:683-685.
9. Wand M, Gilbert CM, Liesegang TJ: Latanoprost and herpes simplex keratitis. Am J Ophthalmol 1999;127:602-604.
10. Kroll DM, Schuman JS: Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol 2002;133:401-403.
11. Fechtner RD, Khouri AS, Zimmerman TJ, et al: Anterior uveitis associated with latanoprost. Am J Ophthalmol 1998;126:37-41.
12. Parentin F: Granulomatous anterior uveitis associated with bimatoprost. A case report. Ocul Immunol Inflamm 2003;11:67-71.
13. Moroi SE, Gottfredsdottir MS, Schteingart MT, et al: Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 1999;106:1024-1029.
14. Miyake K, Ibaraki N: Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002;47(suppl 1):S203-S218.
15. Warwar RE, Bullock JD: Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. Ophthalmology 1998;105:263-268.
16. Callanan D, Fellman RL, Savage JA: Latanoprost-associated cystoid macular edema. Am J Ophthalmol 1998;126:134-135.
17. Wand M, Gaudio AR: Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol 2002;133:403-405.
18. Eakins KE, Whitelocke RAF, Bennet A: Prostaglandin-like activity in ocular inflammation. Br Med J 1972,3:452-453.
19. Jampol LM: Aphakic cystoid macular edema: A hypothesis. Arch Ophthalmol 1985;103:1134-1135.
20. Hogan MH, Kimura SJ, Thygeson P: Signs and symptoms of uveitis. Anterior uveitis. Am J Ophthalmol 1959;47:155-170.
21. Anjou CIN, Krakau CET: A photographic method for measuring the aqueous flare of the eye in normal and pathological conditions. Acta Ophthalmol 1960;38:178-224.
22. Dyster-Aas HK, Krakau CET: A photo-electric instrument for measuring the aqueous flare in the intact eye. Ophthalmologica 1963;146:48-56.
23. Cunha-Vaz JG: The blood-retinal barriers. Doc Ophthalmol 1976;41:287-327.
24. Zeimer RC, Cunha-Vaz JG, Johnson ME: Studies on the technique of vitreous fluorophotometry. Invest Ophthalmol Vis Sci 1982;22:668-674.
25. Sawa M: Clinical application of laser flare-cell meter. Jpn J Ophthalmol 1990;34:346-363.
26. Ziai N, Dolan J, Kacere R: The effects on aqueous dynamics of PhXA41, a new prostaglandin F analogue, after topical application in normal and ocular hypertensive human eyes. Arch Ophthalmol 1993;111:1351-1358.
27. Yousufzai SY, Abdel-Latif AA: Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species. Exp Eye Res 1996;63:305-310.
28. Kozawa O, Tokuda H, Miwa M: Mechanism of prostaglandin E2-induced arachidonic acid release in osteoblast-like cells: Independence from phosphoinositide hydrolysis. Prostaglandins Leukot Essent Fatty Acid 1992;46:291-295.
29. Maxey KM, Johnson JL, LeBrecque J: The hydrolysis of bimatoprost in corneal tissue generates a potent prostanoid FP receptor agonist. Surv Ophthalmol 2002;47(suppl):S34-S40.
30. Yu M, Ives D, Ramesha CS: Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2. J Biol Chem 1997;272:21181-21186.